1-Ethyl-3-(3'-dimethylaminopropyl)carbodiimide → HCID 178461065, compound
Reaction equation
[NH2:1][C:2]1[CH:3]=[C:4]2[C:10]([CH2:11][OH:12])=[N:9][NH:8][C:5]2=[N:6][CH:7]=1.[F:13][C:14]1[C:22]([NH:23][S:24]([CH2:27][CH2:28][CH3:29])(=[O:26])=[O:25])=[CH:21][CH:20]=[C:19]([F:30])[C:15]=1[C:16](O)=[O:17].CCN=C=NCCCN(C)C.C1C=CC2N(O)N=NC=2C=1>CN(C=O)C>[F:13][C:14]1[C:22]([NH:23][S:24]([CH2:27][CH2:28][CH3:29])(=[O:25])=[O:26])=[CH:21][CH:20]=[C:19]([F:30])[C:15]=1[C:16]([NH:1][C:2]1[CH:3]=[C:4]2[C:10]([CH2:11][OH:12])=[N:9][NH:8][C:5]2=[N:6][CH:7]=1)=[O:17]Participants
6
Reactant 4
Product 1
Reagents, catalysts & solvents 1
Procedure
(5-Amino-1H-pyrazolo[3,4-b]pyridin-3-yl)methanol (0.040 g, 0.675 mmol), 2,6-difluoro-3-(propylsulfonamido)benzoic acid (0.071 g, 0.256 mmol), EDCI (0.049 g, 0.256 mmol) and HOBt (0.033 g, 0.244 mmol) were dissolved in DMF (0.53 mL) and stirred at room temperature for 16 hours. The reaction mixture was directly purified by reverse phase HPLC to give 2,6-difluoro-N-(3-(hydroxymethyl)-1H-pyrazolo[3,4-b]pyridin-5-yl)-3-(propylsulfonamido)benzamide (0.051 g, 49%) as a solid. 1H NMR (400 MHz, d6-DMSO) δ 13.37 (s, 1H), 11.05 (s, 1H), 9.93 (br s, 1H), 8.74 (d, 1H), 8.58 (d, 1H), 7.58-7.52 (m, 1H), 7.26 (t, 1H), 5.36 (t, 1H), 4.78 (d, 2H), 3.12 (m, 2H), 1.77 (m, 2H), 1.00 (t, 3H); m/z (ES-MS) 426.1 (98.0%) [M+1].
Workup
- customThe reaction mixture was directly purified by reverse phase HPLC
Sources & evidence
- ORD record
- ord-9d999af1ea6148cfb5dcc912dd6d6f23
- Source dataset
- uspto-grants-2013_03
- Patent number
- US08394795B2
Reaction notes
Loading…